April 27, 2006

Dear Mr. White, We are writing to you to express our concern about the lack of availability in developing countries of the new melt extrusion (Meltrex) formulation of lopinavir/ritonavir (LPV/r), marketed as Kaletra (200/50mg tablets).

January 23, 2006

A Statement Delivered by Helen O'Neill, Deputy Director of Operations, Médecins Sans Frontières (MSF) at the United Nations Security Council "Arria Formula" meeting